These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32819797)

  • 1. Glucose-6-phosphate dehydrogenase deficiency associated hemolysis in COVID-19 patients treated with hydroxychloroquine/chloroquine: New case reports coming out.
    De Franceschi L; Costa E; Dima F; Morandi M; Olivieri O
    Eur J Intern Med; 2020 Oct; 80():103. PubMed ID: 32819797
    [No Abstract]   [Full Text] [Related]  

  • 2. Linking hydroxychloroquine to hemolysis in a 'suspected' glucose-6-phosphate dehydrogenase deficient patient with COVID-19 infection - a critical appraisal.
    Afra TP; Nampoothiri RV; Razmi T M; Hafi NAB
    Eur J Intern Med; 2020 Oct; 80():101-102. PubMed ID: 32651040
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucose-6-phosphate dehydrogenase deficiency-associated hemolysis and methemoglobinemia in a COVID-19 patient treated with chloroquine.
    Kuipers MT; van Zwieten R; Heijmans J; Rutten CE; de Heer K; Kater AP; Nur E
    Am J Hematol; 2020 Aug; 95(8):E194-E196. PubMed ID: 32390140
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 infection and treatment with hydroxychloroquine cause severe haemolysis crisis in a patient with glucose-6-phosphate dehydrogenase deficiency.
    Beauverd Y; Adam Y; Assouline B; Samii K
    Eur J Haematol; 2020 Sep; 105(3):357-359. PubMed ID: 32324284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emergence of methemoglobinemia amidst the COVID-19 pandemic.
    Naymagon L; Berwick S; Kessler A; Lancman G; Gidwani U; Troy K
    Am J Hematol; 2020 Aug; 95(8):E196-E197. PubMed ID: 32413176
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent Findings on Cardiovascular Safety With the Use of Chloroquine and Hydroxychloroquine for COVID-19.
    Guzman-Prado Y
    Am J Cardiol; 2020 Sep; 130():162-163. PubMed ID: 32624192
    [No Abstract]   [Full Text] [Related]  

  • 7. A case report of serious haemolysis in a glucose-6-phosphate dehydrogenase-deficient COVID-19 patient receiving hydroxychloroquine.
    Maillart E; Leemans S; Van Noten H; Vandergraesen T; Mahadeb B; Salaouatchi MT; De Bels D; Clevenbergh P
    Infect Dis (Lond); 2020 Sep; 52(9):659-661. PubMed ID: 32496938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 9. Chloroquine and hydroxychloroquine for COVID-19: implications for cardiac safety.
    Jeevaratnam K
    Eur Heart J Cardiovasc Pharmacother; 2020 Jul; 6(4):256-257. PubMed ID: 32347923
    [No Abstract]   [Full Text] [Related]  

  • 10. Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).
    Gao J; Hu S
    Biosci Trends; 2020 May; 14(2):156-158. PubMed ID: 32281583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chloroquine, Hydroxychloroquine, Retinal Toxicity, and COVID-19.
    Wiwanitkit V
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):374. PubMed ID: 32740070
    [No Abstract]   [Full Text] [Related]  

  • 12. Could Chloroquine /Hydroxychloroquine Be Harmful in Coronavirus Disease 2019 (COVID-19) Treatment?
    Guastalegname M; Vallone A
    Clin Infect Dis; 2020 Jul; 71(15):888-889. PubMed ID: 32211771
    [No Abstract]   [Full Text] [Related]  

  • 13. The friendly use of chloroquine in the COVID-19 disease: a warning for the G6PD-deficient males and for the unaware carriers of pathogenic alterations of the G6PD gene.
    Capoluongo ED; Amato F; Castaldo G
    Clin Chem Lab Med; 2020 Jun; 58(7):1162-1164. PubMed ID: 32333649
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Chloroquine (CQ) and Hydroxychloroquine (HQ) Retinal Toxicity Consideration in the Treatment of the Coronavirus Disease 2019 (COVID-19).
    Ruamviboonsuk P; Lai TYY; Chang A; Lai CC; Mieler WF; Lam DSC
    Asia Pac J Ophthalmol (Phila); 2020; 9(4):375-376. PubMed ID: 32740072
    [No Abstract]   [Full Text] [Related]  

  • 15. Update Alert: Hydroxychloroquine or Chloroquine for the Treatment or Prophylaxis of COVID-19.
    Hernandez AV; Roman YM; Pasupuleti V; Barboza JJ; White CM
    Ann Intern Med; 2020 Aug; 173(4):W78-W79. PubMed ID: 32667853
    [No Abstract]   [Full Text] [Related]  

  • 16. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 17. Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
    Palmeira VA; Costa LB; Perez LG; Ribeiro VT; Lanza K; Silva ACSE
    Clinics (Sao Paulo); 2020; 75():e1928. PubMed ID: 32401962
    [No Abstract]   [Full Text] [Related]  

  • 18. Benefit v. risk when using chloroquine in patients with severe COVID-19 disease.
    Decloedt EH; Reuter H; Allwood B; Parker A; Koegelenberg CFN; Blockman M; Taljaard J
    S Afr Med J; 2020 Apr; 110(5):12903. PubMed ID: 32657706
    [No Abstract]   [Full Text] [Related]  

  • 19. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Allam MF; Andraous F
    Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19 and hydroxychloroquine: Let the available data speak for themselves.
    Paliani U; Cardona A
    Eur J Intern Med; 2020 Oct; 80():121. PubMed ID: 32709544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.